CDMO Avid Bioservices
- 12.350
- +0.020+0.16%
Avid Bioservices News
Stephens Maintains Avid Bioservices(CDMO.US) With Hold Rating, Maintains Target Price $12.5
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Hold Rating
Craig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)
Stephens Downgrades Avid Bioservices(CDMO.US) to Hold Rating, Raises Target Price to $12.5
Craig-Hallum Downgrades Avid Bioservices(CDMO.US) to Hold Rating
Stephens Downgrades Avid Bioservices to Equalweight, Price Target Is $12.50
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Avid Bioservices Downgraded to Hold From Buy at Craig-Hallum
RBC Capital Downgrades Avid Bioservices(CDMO.US) to Hold Rating, Raises Target Price to $12.5
Avid Bioservices Analyst Ratings
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating, Announces Target Price $16
RBC Capital Maintains Avid Bioservices(CDMO.US) With Buy Rating, Raises Target Price to $12
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Initiates Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Releases a Buy Rating on Avid Bioservices (CDMO)
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Avid Bioservices (CDMO)
No Data